NERVGEN PHARMA CORP. Key Management Personnel Compensation Share-based Payment
NERVGEN PHARMA CORP. (NGEN) reported Key Management Personnel Compensation Share-based Payment of CAD 3.59 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment · last filed 2026-03-31
| Period end | Key Management Personnel Compensation Share-based Payment 12 month |
|---|---|
| 2025-12-31 | 3.59M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 4.21M CAD 40-F · filed 2026-03-31 |